Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Shares Issued (2016 - 2024)

Historic Shares Issued for Rocket Pharmaceuticals (RCKT) over the last 8 years, with Q4 2024 value amounting to $321000.0.

  • Rocket Pharmaceuticals' Shares Issued fell 1769.23% to $321000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $321000.0, marking a year-over-year decrease of 9021.34%. This contributed to the annual value of $3.2 million for FY2024, which is 4392.65% up from last year.
  • According to the latest figures from Q4 2024, Rocket Pharmaceuticals' Shares Issued is $321000.0, which was down 1769.23% from $176000.0 recorded in Q3 2024.
  • In the past 5 years, Rocket Pharmaceuticals' Shares Issued ranged from a high of $279.9 million in Q4 2020 and a low of -$45.9 million during Q4 2022
  • Its 5-year average for Shares Issued is $15.7 million, with a median of $538000.0 in 2020.
  • As far as peak fluctuations go, Rocket Pharmaceuticals' Shares Issued tumbled by 20551.01% in 2022, and later surged by 2256052.63% in 2023.
  • Quarter analysis of 5 years shows Rocket Pharmaceuticals' Shares Issued stood at $279.9 million in 2020, then plummeted by 105.37% to -$15.0 million in 2021, then plummeted by 205.51% to -$45.9 million in 2022, then soared by 100.85% to $390000.0 in 2023, then fell by 17.69% to $321000.0 in 2024.
  • Its Shares Issued stands at $321000.0 for Q4 2024, versus $176000.0 for Q3 2024 and $1.5 million for Q2 2024.